NMDAR2B Recombinant Rabbit mAb (S-1864-37)
Glutamate receptor ionotropic,NMDA 2B,GluN2B,Glutamate [NMDA] receptor subunit epsilon-2,N-methyl D-aspartate receptor subtype 2B (NMDAR2B,NR2B),N-methyl-D-aspartate receptor subunit 3 (NR3,hNR3),GRIN2B
产品介绍 FAQs 评论(0)
宿主来源
Rabbit抗原名称
NMDAR2B分子别名
Glutamate receptor ionotropic, NMDA 2B; GluN2B; Glutamate [NMDA] receptor subunit epsilon-2; N-methyl D-aspartate receptor subtype 2B (NMDAR2B; NR2B); N-methyl-D-aspartate receptor subunit 3 (NR3; hNR3); GRIN2B免疫原
Synthetic Peptide细胞定位
Cytoskeleton, Lysosome, Endosome, Cell membrane, CytoplasmAccession
Q13224克隆号
S-1864-37抗体类型
Recombinant mAb抗体同种型
IgG反应种属 ?
Ms阳性样本
Mouse brain纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
WB
稀释度
应用 稀释度 推荐种属 WB 1:1000 Ms
NMDAR2B protein, also known as GRIN2B or GluN2B, is a subunit of the N-methyl-D-aspartate (NMDA) receptor, which is a ligand-gated ion channel that plays a crucial role in synaptic plasticity, learning, and memory formation. It is highly expressed in the brain and is involved in long-term potentiation, an activity-dependent increase in synaptic transmission efficiency underlying certain types of memory. NMDAR2B is essential for brain development and synaptic function, with its phosphorylation at specific sites regulating receptor activity and localization. Additionally, NMDAR2B has been implicated in various neurological disorders, such as Alzheimer’s disease, epilepsy, and ischemic neuronal cell death. Recent studies also suggest its involvement in cancer progression, where it can be phosphorylated and interact with other proteins to enhance cell migration and invasion.
免疫印迹
WB result of NMDAR2B Recombinant Rabbit mAb
Primary antibody: NMDAR2B Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: mouse liver lysate 20 µg
Lane 2: mouse brain lysate 20 µg
Negative control: mouse liver lysate
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 166 kDa
Observed MW: 180 kDa
FAQs
我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定







评论(0)